A DEVICE FOR FRACTIONATING A SUSPENSION SAMPLE

Abstract

The present invention relates to a device for fractionating a suspension sample and to uses of such device. Furthermore, the present invention also relates to a method of fractionating a suspension sample into a liquid phase and a solid phase. The present invention also relates to a device and method for separating a sample comprising a solvent and two or more components having different molecular weights and being dissolved in said solvent, into said two or more components.

Claims

1. A device configured for separating a sample comprising a solvent and two components having different molecular weights and being dissolved in said solvent, into said two components, or for fractionating a suspension sample into a liquid phase and a solid phase, said device comprising at least one polymeric matrix element, said polymeric matrix element comprising a porous polymeric scaffold and an interstitial pore space within said polymeric scaffold, wherein said porous polymeric scaffold is composed of a polymer responsive to the change of at least one external condition to which said polymeric matrix element, during use of said device, is exposed.

2. The device according to claim 1, further comprising at least one sample container, said at least one sample container containing, or being configured to contain, said at least one polymeric matrix element, said at least one sample container being capable of receiving a sample comprising a solvent and two components having different molecular weights and being dissolved in said solvent, or a suspension sample.

3. The device according to claim 1, wherein said at least one polymeric matrix element is either a macroscopic solitary particle or said at least one polymeric matrix element is a macroscopic body or layer immobilized on a surface of a substrate within said device.

4. The device according to claim 1, wherein said at least one polymeric matrix element is detachable or removable from said device.

5. The device according to claim 1, wherein said device further comprises means to effect a change of at least one external condition to which said polymeric matrix element, during use of said device, is exposed.

6. The device according to claim 5, wherein said means are configured to expose said at least one polymeric matrix element to a change of at least one external condition, wherein preferably said means are part of said device and/or are integrated in said device and/or are configured to come into contact with said suspension sample or to become connected with said suspension sample.

7. The device according to claim 1, wherein said device further comprises a carrier tool configured to allow the handling of said at least one polymeric matrix element, said carrier tool acting as a substrate having a surface on which said at least one polymeric matrix element is immobilized, said carrier tool being dimensioned such as to be able to be dipped into a sample comprising a solvent and two components having different molecular weights and being dissolved in said solvent, or into a suspension sample, and such as to be able to bring said at least one polymeric matrix element into contact with said sample.

8. The device according to claim 7, wherein said carrier tool is configured to be able to effect a change of at least one external condition to which said polymeric matrix element, during use of said device, is exposed.

9. The device according to claim 8, wherein said carrier tool comprises heating and/or cooling means for heating and/or cooling said at least one polymeric matrix element, or said carrier tool is connected to or contacted with heating and/or cooling means for heating and/or cooling said at least one polymeric matrix element.

10. The device according to claim 7, wherein said carrier tool is a disposable single-use carrier tool and is configured to be detachably connected to, detachably contacted with or to detachably comprise said heating and/or cooling means.

11. The device according to claim 1, wherein said device further comprises at least one liquid phase collection container, said at least one liquid phase collection container being configured to take up said polymeric matrix element and/or a carrier tool, if present, with said polymeric matrix element being immobilized on said carrier tool.

12. The device according to claim 2, wherein a) said sample container and/or a carrier tool, if present, and/or a liquid phase collection container, if present, comprise means to mechanically remove said solid phase from said polymeric matrix element; or b) said sample container and/or a carrier tool, if present, and/or a liquid phase collection container, if present, comprise a material having an affinity to said solid phase to which material said solid phase adheres, when being or getting in contact with it; or c) said sample container and/or a carrier tool, if present, and/or a liquid phase collection container, if present, comprise means to wash off said solid phase from said polymeric matrix element; or d) wherein said device further comprises a separate tool to remove said solid phase from said polymeric matrix element.

13. The device according to claim 1, wherein said sample comprising a solvent and two components having different molecular weights and being dissolved in said solvent is an aqueous sample comprising a macromolecular component as one of the two components and a small molecule component as another of the two components, or wherein said suspension sample is a whole blood sample, said liquid phase of said whole blood sample is blood plasma, and said solid phase of said whole blood sample is, or comprises, blood cells of said whole blood sample.

14. The device according to claim 1, wherein said polymer responsive to the change of at least one external condition to which said polymeric matrix element, during use of said device, is exposed, is a thermoresponsive polymer which is either a thermoresponsive polymer having a lower critical solution temperature (LCST polymer), or said thermoresponsive polymer is a thermoresponsive polymer having an upper critical solution temperature (UCST).

15. The device according to claim 1, wherein said interstitial pore space has pores the average diameter of which is <5 μm.

16. The device according to claim 1, wherein said device is dimensioned such as to fractionate a suspension sample having a volume in the range of from 10 μl to 500 μl, and wherein the interstitial pore space has a volume which takes up at least 50% of said suspension sample.

17. A method of fractionating a suspension sample into a liquid phase and a solid phase, said method comprising the steps: a) providing, in any order, but separately from each other, a device according to claim 1, and a suspension sample, wherein said at least one polymeric matrix element of said device is in dry state, or wherein said at least one polymeric matrix element of said device is provided under conditions in which said responsive polymer is in a contracted state but wherein said at least one polymeric matrix element of said device is in a moist state; b) exposing said at least one polymeric matrix element of said device to said suspension sample under an external condition allowing said polymeric matrix element to reversibly adopt an expanded state and thus allowing a liquid phase in said suspension sample to enter said interstitial pore space of said at least one polymeric matrix element, whilst excluding a solid phase in said suspension sample from said interstitial pore space; and c) removing said at least one polymeric matrix element from said sample, thereby removing said liquid phase contained within said interstitial pore space from said sample and thereby separating said liquid phase from a solid phase in said sample.

18. The method according to claim 17, wherein, in step c), said at least one polymeric matrix element is removed from a sample container and is transferred to a liquid phase collection container.

19 The method according to claim 17, said method further comprising the step: d) changing an external condition to which said polymeric matrix element is exposed, to a condition allowing said polymeric matrix element to reversibly adopt a contracted state, thereby releasing said liquid phase from said polymeric matrix element.

20. A method for fractionating a whole blood sample into blood plasma and blood cells, wherein said method comprises use of a device, as defined in claim 1.

Description

[0090] Furthermore, the present invention is illustrated by the figures, wherein

[0091] FIG. 1 shows one embodiment of a device according to the present invention comprising a polymeric matrix element contained within a sample container which is used to fractionate a blood sample.

[0092] FIG. 2 (A)-C)) shows photographs of a fractionation performed in accordance with the principles shown in FIG. 1, and (D) the results of a cell count analysis performed with samples fractionated in accordance with the present invention.

[0093] FIG. 3 shows another embodiment of a device according to the present invention wherein a polymeric matrix element is immobilized on a carrier tool which is configured to be detachably connected to heating and/or cooling means.

[0094] FIG. 4 shows an embodiment of a carrier tool with a polymeric matrix element immobilized on surface of carrier tool;

[0095] FIG. 5 shows a prototype of an embodiment of a hand-held instrument including heating and/or cooling means (A)=exploded view, and B)=assembled device), and (C) an embodiment of a device for fractionation, including a disposable carrier tool with immobilized polymeric matrix element and heating and/or cooling means in accordance with the present invention.

[0096] FIG. 6(A)-F)) shows the results of a plasma separation process for a whole blood sample using a plasma separation device, as exemplified in FIG. 5.

[0097] FIG. 7 shows fluorescence emission spectra of a stock solution of carboxy-fluorescein and R-phycoerythrin (R-PE), of the same stock solution after having been exposed to two different polymeric matrix elements at room temperature (during which exposure part of the stock solution will be able to enter the interstitial pore space of said polymeric matrix element), and of liquid expelled from the two different polymeric matrix elements after these have been heated to 40° C.

[0098] More specifically, FIG. 1 shows a sample container with a polymeric matrix element which is in a dry state. After addition of the sample to the sample container, the polymeric matrix element is wetted, and liquid is taken up by the polymeric matrix element, whereas the solid phase within the sample remains outside of the polymeric matrix element. Upon contact with the liquid, the polymeric matrix element swells considerably and enlarges its volume by a factor of approximately 10×. The remaining sample which is not incorporated into the polymeric matrix element is a more or less solid phase or an enriched sample of the suspended members, for example cells. In contrast thereto, the polymeric matrix element itself contains the liquid phase of said sample without the excluded suspended solid members. In the case of a blood sample, the incorporated liquid phase would be blood plasma. Depending on the size of the pores within the polymeric matrix element, this may be plasma with or without platelets. In a further step, the phase with the enriched solid phase may be removed from the sample container, or the liquid phase may be removed by removing the polymeric matrix element from the sample container. Subsequently, the polymeric matrix element is exposed to conditions in which the polymer contracts again, thus reducing the pore size of the polymeric matrix element and thus displacing the liquid from the polymeric matrix element. For example, if the polymer is a LCST polymer, such contraction can be achieved by increasing the temperature to a temperature above the LCST. The thus released liquid phase, e.g. the released plasma may be collected from the container.

[0099] FIG. 2 shows the results of a fractionation performed in accordance with the principles outlined for FIG. 1. More specifically, 4 different polymeric matrix elements were produced as macroscopic solitary particles and were exposed to whole blood (A), and after a defined incubation removed therefrom and placed into separate further containers (B). They were then exposed to conditions allowing the release of liquid phase (plasma) from said polymeric matrix element (C). FIG. 2 D) shows the results of a cell count analysis of different samples treated in FIGS. 2A)-C) and of whole blood and of centrifugal plasma.

[0100] FIG. 3 shows another embodiment of a device in accordance with the present invention and its use. In this embodiment, a sample container containing a suspension sample is provided, and a polymer matrix element which is attached to a carrier tool is introduced into the suspension sample. The carrier tool is preferably heat conducting, and thus, the temperature to which the polymeric matrix element is exposed, can be easily changed by coupling the carrier tool to a heating and/or cooling means. Upon contact of the polymeric matrix element with the suspension sample, the polymeric matrix element takes up the liquid and excludes the suspended solid phase, e.g. cells. Again, taking blood as an example, plasma will be collected within the polymeric matrix element, until the capacity of the pores within the interstitial pore space is reached. Subsequently, the polymeric matrix element is then removed from the sample container and is transferred to a further container, i.e. a container for collecting a liquid phase (herein also sometimes referred to as “liquid phase collection container”), where again, the external conditions are changed so as to shift the polymeric matrix element from an expanded state to a contracted state, thus releasing the liquid incorporated in the polymeric matrix element. If the responsive polymer of the polymeric matrix element is a LCST polymer the change of external conditions will be an increase of the temperature above the LCST.

[0101] FIG. 4 shows an embodiment of a carrier tool with a polymeric matrix element immobilised on the surface of said carrier tool, in accordance with the present invention;

[0102] FIG. 5 shows an embodiment of a hand-held instrument that forms part of the device according to the present invention, including heating and/or cooling means, in this case a heating rod, which is configured to connect with a polymeric matrix element immobilized on a disposable carrier tool. Panel A shows an exploded view of the hand-held instrument, panel B shows the hand-held instrument in assembled form; panel C) shows an embodiment of a device for fractionation according to the present invention, including a disposable carrier tool with immobilized polymeric matrix element and heating and/or cooling means (here: heating rod);

[0103] FIG. 6 shows the results of a plasma separation process using a plasma separation device, as exemplified in FIG. 5, with the panels A)-F) showing the different stages of the separation process: Panel A) shows an embodiment of a sample container containing whole blood; panel B) shows the disposable carrier tool (as shown in FIG. 4) with a polymeric matrix element immobilized thereon inserted into said sample container; panel C) shows the hand-held instrument of FIG. 5 being connected with said disposable carrier tool by way of said heating and/or cooling means (heating rod); panel D) shows the combination of said hand-held instrument of FIG. 5 with said disposable carrier tool, after it has been withdrawn from said sample container; panel e) shows the combination of said hand-held instrument of FIG. 5 with said disposable carrier tool after it has been inserted into a new container (“a liquid phase collection container”); and panel F) shows both the (first) sample container and the liquid phase collection container after said combination of said hand-held instrument of FIG. 5 with said disposable carrier tool has been withdrawn therefrom.

[0104] FIG. 7 shows fluorescence emission spectra of a stock solution of carboxy-fluorescein and R-phycoerythrin (R-PE), of the same stock solution after having been exposed to two different polymeric matrix elements at room temperature (during which exposure part of the stock solution will be able to enter the interstitial pore space of said polymeric matrix element), and of liquid expelled from the two different polymeric matrix elements after these have been heated to 40° C. A depletion of R-Phycoerythrin from the liquid that enters the polymeric matrix elements (and a corresponding enrichment in the liquid that cannot enter the polymeric matrix element, “supernatant”) can be seen.

[0105] Furthermore, reference is made to the following examples which are given to illustrate, not to limit the present invention.

EXAMPLES

Example 1

Embodiment Describing Preparation of Polymeric Matrix Element Within a Sample Container and Its Application for Plasma Separation

[0106] Four different formulations of LCST polymer matrix have been prepared and accommodated in a sample container.

[0107] The applied protocol was as following. First a solution containing the N-Isopropylacrylamide (NIPAM) and N,N′-Methylenebisacrylamide (BIS) monomers and Ammoniumpersulfate (APS)was prepared (Premix NBA).

TABLE-US-00001 Premix NBA 20% NIPAM 2618.6 μl 2% BIS 448 μl 5% APS 800 μl

[0108] In order to assess the impact for different additives to the formulation the following variants were prepared:

TABLE-US-00002 Matrix Matrix Matrix Matrix 1 2 3 4 Premix NBA 870 μl 870 μl 870 μl 870 μl 20% PEG methyl ether 60 μl 0 μl 0 μl 0 μl acrylate, average Mn 2000 20% PEG methyl ether 0 μl 60 μl 306 μl 0 μl acrylate average Mn 480 ddWater 246 μl 246 μl 0 μl 306 μl

[0109] Plugs (i.e. “macroscopic solitary particles”) of approximately 100 μL were thus formed in 0.5 mL micro reaction vials by mixing the liquid with 2 μL of 5% TEMED (degassed) under Argon. Afterwards, polymerization was allowed to occur for 30 minutes at room temperature.

[0110] The vials have been placed on a heat block at a temperature of 50° C. Shrinking of the polymer could be readily observed. The expelled liquid has been collected with a micropipette and discarded. The plugs have been taken out of the micro reaction vials and transferred to 2 ml reaction tubes. 500 μl of PBS buffer were added to the tubes followed by an incubation at 20° C. for 1 hour to reswell the polymer. The PBS in excess was remover and the tubes were incubated at 60° C. for 15 min to allow the polymers to shrink. The expelled liquid was discarded. This washing procedure was repeated once more.

[0111] Samples of 150 μL of whole blood freshly collected in EDTA coated vacutainer tubes have been added to the respective vials containing the shrunken polymer as shown in FIG. 2A), and left for 30 minutes at room temperature.

[0112] After 30 minutes the sample was removed from the vials with the swollen plugs. FIG. 2B) shows the four vials with the plugs. It is apparent that the different matrices have taken up different amounts of liquid. Moreover, different amounts of whole blood have stuck to the plugs depending on their formulation.

[0113] The vials with the plugs have then been placed on a heating block for one minute at 40° C. The polymer contracted and liquid was expelled from the matrix material. The expelled liquid has been collected in separate vials. As shown in FIG. 2C), different amounts of liquid have been expelled at the defined temperature, also different levels of coloring of the sample due to trapped whole blood can be seen.

[0114] The collected samples have been analyzed on a laboratory hematology analyzer (Sysmex) and data have been compared against the cell counts (“WBC”=white blood cells; “RBC”=red blood cells; and “PLT”=platelets) obtained with whole blood and plasma generated by centrifuging a sample of 250 μl at 1.500 g for 1 minute. Data for two aliquots of one sample of whole blood (“Whole Blood #1” and “Whole Blood#2”), two plasma samples generated by centrifugation from the same sample of whole blood (“Centrifugal Plasma#1” and “Centrifugal Plasma#2”) and data for liquid collected from the different formulation of the LCST polymer matrices (“Matrix 1”, “Matrix 2”, “Matrix 3”, “Matrix 4”) are summarized in FIG. 2D).

[0115] The separating effect achieved by the application of the matrix is clearly visible. Moreover a simple approach to optimizing the separating effect by adding different reagents to the polymer preparation is shown. It appears that matrices 1 and 2 are the most efficient ones in separating blood cells from the liquid components of the blood sample.

Example 2

Polymeric Matrix Element Immobilized on a Substrate

[0116] An aluminum shell has been designed as a part of a disposable for plasma separation. The aluminum shell functions as carrier tool acting as a substrate having a surface on which a polymeric matrix element is immobilized. The shell surface has been roughened with sandpaper to make a polymeric matrix element better adhere to the surface.

[0117] A formulation of a LCST polymer matrix as polymeric matrix element has been prepared as follows: First, a solution containing N-Isopropylacrylamide (NIPAM) and N,N′-Methylenebisacrylamide (BIS) monomers and Ammoniumpersulfate (APS) was prepared (Premix NBA).

TABLE-US-00003 Premix NBA 20% NIPAM 655 μl 2% BIS 112 μl 5% APS 200 μl

[0118] To this mix a PEG methyl ether acrylate and water was added as follows:

TABLE-US-00004 LCST-Mix Premix NBA 870 μl 20% PEG methyl ether 120 μl acrylate average Mn 480 ddWater 186 μl

[0119] 194 μl aliquots of this solution was added to Sarsted Microvette sampling vessels. The solution in the vessels has been degassed and saturated with Argon in 4 push pull cycles.

[0120] These aliquots were mixed with 4 μl of 5% TEMED (degassed) under Argon and the aluminum shell was dipped into the solution. Following an incubation time of 30 minutes the aluminum shell has been contacted to a heat source and the polymer contracted on the shell. The shell with the polymer has been removed from the vial and transferred into a new vial containing PBS washing buffer. The polymer was allowed to reswell in the washing buffer for one hour. This washing step has been repeated two times.

[0121] This disposable device is shown in FIG. 4 and is subsequently used as a carrier tool according to the exemplary process described in Example 3.

Example 3

Description of Prototype as Developed by Blink AG

[0122] As a possible product based on the invention, a handheld separation device has been developed. Such a product may be particularly useful in the context of enabling diagnostics applications at the point-of-care. Many diagnostic tests require plasma as the sample matrix. However, in many settings no adequate means are available for generating plasma from whole blood, in particular from capillary blood samples that otherwise can be easily obtained by common fingerstick sampling techniques. Here we describe a pen-like hand-held battery-operated instrument in combination with a disposable device.

[0123] The instrument consists of the basic modules shown in FIGS. 5A) (exploded view) and 5B) (assembled device) which is to be used in conjunction with a disposable carrier tool as shown in FIG. 4. The combination of the hand-held device of FIGS. 5A) and B) with a disposable carrier tool is an embodiment of a device configured for fractionation in accordance with the present invention and is shown in FIG. 5C)

[0124] The hand-held instrument of FIGS. 5A) and 5B) is designed to heat a metal rod to a predefined temperature (above the LCST of the filter polymer). The control circuit is accommodated on a separate electronics board containing a power management circuit connected to an AA battery accommodated within the instrument body, a LED for reporting the status of the device as well as a button for activating the device. The control circuit is connected to a heating rod ((“heating and/or cooling means”) with dimensions allowing it to be combined with and introduced into a special “disposable carrier tool” (as e.g. shown in FIG. 4) with a LCST-polymer coating acting as a polymeric matrix element immobilized on a surface of said carrier tool.

[0125] The “disposable carrier tool”-device comprises a plastic part equipped with a pit to accommodate tightly the heating rod of the device. On its outer face the disposable carrier tool is coated with the LCST polymer as outlined in example 2 and shown in FIG. 4.

[0126] The disposable carrier tool is designed to fit into a sample container, e.g. a standard Microvette sample container containing a required amount, e.g. 100 μL, of collected whole blood. Upon introduction of the disposable carrier tool into the sample container the plasma wets the polymer and occupies its inner space whereas any particular materials contained in the sample remain outside of the polymer matrix. After a sufficient incubation time the disposable carrier tool is brought into contact with the hand-held instrument of FIGS. 5A) and 5B) and the heating and/or cooling means thereof, i.e. the heating rod, by introducing the heating rod of the instrument into the pit of the disposable carrier tool. By firmly pressing the rod into the disposable carrier tool, the latter is attached to the former. Then the instrument with the disposable carrier tool attached is removed from the sample container, and the disposable carrier tool is introduced into another container, i.e. an empty container (“a liquid phase collection container”). Upon pushing the button, the hand-held instrument is activated. A green (or any other suitable color) LED flashes until a predefined temperature above the LCST has been reached. The LED now lights up permanently in green. The polymer shrinks in the disposable carrier tool and releases the trapped plasma into the liquid phase collection container. The disposable carrier tool is withdrawn from the liquid phase collection container, removed from the hand-held instrument of FIGS. 5A and 5B and safely discarded. The hand-held instrument can now be used for a new separation task. The device is switched off by once pressing the button. Any malfunctions are indicated by a red light.

[0127] The whole workflow is shown in FIGS. 6A)-F), wherein FIG. 6A) shows a standard sample container containing a suspension sample, in this case whole blood; FIG. 6B) shows the disposable carrier tool of FIG. 4 (with a polymeric matrix element immobilised thereon) inserted into said sample container such that the polymeric matrix element gets exposed to said suspension sample, i.e. in this case to said whole blood; FIG. 6C) shows the disposable carrier tool connected with the heating and/or cooling means (in this case the heating rod) of the hand-held device of FIG. 5); FIG. 6D) shows the combination of the disposable carrier tool and hand-held device having been withdrawn from the sample container after it had been exposed to said suspension sample for a defined period of time and after the liquid phase had been bound by or incorporated into said polymeric matrix element; FIG. 6E) shows the same combination (of the disposable carrier tool and hand-held device) being introduced into a further, empty container, i.e. a liquid phase collection container, where the heating and/or cooling means, in this case the heating rod, is operated to heat above the LCST of said polymeric matrix element, thereby releasing the liquid phase bound by said polymeric matrix element, into said liquid phase collection container; FIG. 6E) (on the left side) shows the (first) sample container where the whole blood had been originally kept in and exposed to said polymeric matrix element and (on the right side) the (further) liquid phase collection container into which the liquid phase has been released after the heating rod has been heated above the LCST of the polymeric matrix element.

Example 4

Enrichment and Depletion of Soluble Fluorescent Compounds of Different Size

[0128] The invented methodology has been applied for the enrichment of soluble molecules in a solution in a small volume of a liquid.

[0129] Polymer plugs (i.e. “polymeric matrix elements”) prepared according to the methodology described in Example #1 have been used for changing the composition of a stock solution containing 1,62 μmol/L of the small organic dye 5-Carboxyfluorescein (M=376,32 g/mol; C0537 SIGMA-ALDRICH) (“5CF”) and 0,4 nmol/L of the macromolecular fluorescent protein R-Phycoerythrin (M=250 kDa, Thermo Fisher P801) (“R-PE”). The fluorescent spectrum of the stock solution has been collected using a Lambda 50 Fluorescence Spectrometer (Perkin Elmer). The spectrum is shown in black with a solid line in FIG. 7, with an emission peak for R-PE at @570 nm.

[0130] Two different plugs of LCST polymer matrix prepared as outlined in Example #1 made up of PNIPAM/PEG Acrylate and PNIPAM have been used to investigate the effect of the matrix on the composition of the liquid. The vials containing the plugs have been placed in a heat block at 40° C. for one minute. The expelled liquid has been collected with a micropipette and discarded. 150 μL of the stock solution containing 5-Carboxyfluorescein and R-Phycoerythrin has been added to vials and left at room temperature for 5 minutes. Thereafter the supernatants have been collected and fluorescent spectra obtained for both samples (“Supernatant”). The vials with the plugs have been placed in a heat block at 40° C. for one minute and the expelled liquid collected with a micropipette. Fluorescent spectra have been obtained for the expelled liquid samples (“matrix 1” (empty circles), and “matrix 4” (empty diamonds), respectively) and compared against the spectra for the stock solution (marked black, solid line) and against the supernatants (Matrix 1, filled circles, and matrix 4, filled diamonds. Normalized spectra for the two different matrix preparations and the stock solution are shown in FIG. 7. It can be seen that both polymeric matrix elements are capable of enriching R-Phycoerythrin in the respective supernatant (FIG. 7: “Supernatant Matrix 1”, filled circles, and “Supernatant Matrix 4”, filled diamonds) by excluding the R-Phycoerythrin from the interstitial pore space of the polymeric matrix element and thereby depleting it from the liquid that enters the interstitial pore space of the polymeric matrix element and that it is subsequently released again when the polymeric matrix element is heated above its LCST (FIG. 7: “Expelled Liquid Matrix 1”, empty circles, and “Expelled Liquid Matrix 4”, empty diamonds). Hence, the polymeric matrix elements according to the present invention can be successfully used to separate two dissolved components of different molecular weights, and/or to enrich/deplete them respectively. It is also evident from the data that the different matrix preparations show different capacities to enrich or deplete certain reagents from a solution.

REFERENCES

[0131] 1. Tuck, M. K., et al., Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res, 2009. 8(1): p. 113-7.

[0132] 2. Smith, W. C., Improved method for separating the cellular components of blood samples. 1989, Google Patents.

[0133] 3. Pall David B, R.E.N.Y.U.S., et al., Device and method for blood separation.|Vorrichtung und Verfahren zur Trennung von Blut.|Dispositif et méthode pour la séparation du sang.|Device and method for blood separation|Dispositif et méthode pour la séparation du sang|Vorrichtung und Verfahren zur Trennung von Blut, G.C.N.Y.U.S. Pall Corporation, Editor. 1991: EP.

[0134] 4. Liu, C., et al., Membrane-based, sedimentation-assisted plasma separator for point-of-care applications. Analytical chemistry, 2013. 85(21): p. 10463-10470.

[0135] 5. Nakayama, K. and K. Morimoto, Assessment of accuracy of immediate blood separation method: a novel blood analysis strategy. Environ Health Prev Med, 2011. 16(1): p. 1-5.

[0136] 6. Hagihara Takeaki, O. s. O. k. J. P. and O. s. O. k. J. P. Aoki Satoshi, A compact plasma separator and an apparatus containing the same.|Kompakter Plasmaseparator und Vorrichtung mit einemsolchen Separator.|Séparateur compact de plasma et dispositif contenant un tel séparateur.|A compact plasma separator and an apparatus containing the same|Séparateur compact de plasma et dispositif contenant un tel séparateur|Kompakter Plasmaseparator und Vorrichtung mit einem solchen Separator, C.K.T.J.P. Asahi Medical Co. Ltd, Editor. 1993: EP.

[0137] 7. McNeely Michael Ryan, U.S., AUTOMATIC PLASMA SEPARATION AND METERING|SÉPARATION ET DOSAGE AUTOMATIQUES DU PLASMA, U.S.M.M.R.U.S. McNeely Michael Ryan, Editor. 2017: WO.

[0138] 8. Rueda Ivan, P.C.A.U.S., et al., PROCESSING BLOOD SAMPLES TO DETECT TARGET NUCLEIC ACIDS, C.C.A.U.S.M.I.N.C.U.S.M.I.N.C. Monolythix Inc, Editor. 2017: US.

[0139] 9. Mukherjee, S., et al., Plasma separation from blood: the ‘lab-on-a-chip’ approach. Crit Rev Biomed Eng, 2009. 37(6): p. 517-29.

[0140] 10. Gandhi, A., et al., Studies on thermoresponsive polymers: Phase behaviour, drug delivery and biomedical applications. Asian Journal of Pharmaceutical Sciences, 2015. 10(2): p. 99-107.

[0141] 11. Constantinou, A. P. and T. K. Georgiou, Tuning the gelation of thermoresponsive gels. European Polymer Journal, 2016. 78(Supplement C): p. 366-375.

[0142] 12. de la Rosa, V. R., P. Woisel, and R. Hoogenboom, Supramolecular control over thermoresponsive polymers. Materials Today, 2016. 19(1): p. 44-55.